Veradigm (MDRX) Stock Price
Veradigm Price
Over the last 20 years Veradigm grew revenue by 9.2% annually, reaching 588.02 M USD. Earnings per share have grown at 17.2% per year over the last 17 years. For Veradigm, the net margin of -14.7% is down versus -11.2% a few years ago. The consensus 12-month price target for Veradigm is 18.50 USD, about 273.7% above where the stock trades today. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.
Veradigm stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Veradigm business model & stock analysis
Frequently asked questions about Veradigm
Allscripts Healthcare Solutions Inc is a leading healthcare technology company that provides innovative solutions and services to healthcare organizations. The business model of Allscripts revolves around the development and provision of electronic health record (EHR) systems, practice management software, and other healthcare IT solutions. By offering integrated platforms, Allscripts enables healthcare providers to streamline operations, improve patient care, and enhance clinical outcomes. With a focus on promoting interoperability and connectivity, Allscripts facilitates efficient data exchange across healthcare settings. By leveraging technology and data analytics, Allscripts aims to optimize workflows, enhance decision-making processes, and ultimately improve the overall delivery of healthcare services.
Allscripts Healthcare Solutions Inc is primarily active in the healthcare industry.
The main competitors of Allscripts Healthcare Solutions Inc in the market include Cerner Corporation, Epic Systems Corporation, and Meditech.
Allscripts Healthcare Solutions Inc is a leading healthcare information technology company established in 1986. The company features a rich history and background, having grown from a small startup to a global provider of electronic health records (EHR), practice management systems, and population health management solutions. Allscripts is dedicated to enhancing patient care by empowering healthcare organizations with innovative technology. With a strong presence in the healthcare industry, Allscripts serves over 180,000 physicians and more than 2,500 hospitals worldwide. Continuously evolving and expanding its offerings, Allscripts Healthcare Solutions Inc remains at the forefront of the digital healthcare revolution.
Allscripts Healthcare Solutions Inc has achieved several significant milestones in its history. The company has successfully launched innovative products, expanded its market share, and entered into strategic partnerships within the healthcare industry. Allscripts Healthcare Solutions Inc has also received industry recognition for its excellent performance and dedication to providing high-quality healthcare solutions. By continuously investing in research and development, the company has consistently improved its technology offerings, contributing to the overall advancement of healthcare services. With its commitment to excellence, Allscripts Healthcare Solutions Inc continues to shape the future of healthcare with its groundbreaking solutions and services.
Allscripts Healthcare Solutions Inc is primarily present in the United States of America.
Allscripts Healthcare Solutions Inc represents the values of innovation, collaboration, and patient-centered care. With a commitment to improving healthcare technology, Allscripts aims to transform the way healthcare is delivered and experienced. The company values a collaborative approach, working closely with healthcare providers and patients to develop solutions that enhance clinical outcomes and patient satisfaction. Allscripts prioritizes the use of advanced technology and data analytics to drive better healthcare decision-making and deliver personalized care. Through its comprehensive suite of software and services, Allscripts aims to empower healthcare organizations to deliver efficient, high-quality care to their patients.
Analysts currently set an average price target of 16.17 USD for the Veradigm stock (median: 18.50 USD), implying +226.7 % versus the latest price. The consensus is based on 7 analyst ratings.
7 analysts currently rate the Veradigm stock: 6 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Veradigm share trades at 4.42 EUR (4.95 USD).
The Veradigm share (MDRX) is listed on 4 stock exchanges, including: NASDAQ (MDRX), Frankfurt (AL21.F), München (AL21.MU), Düsseldorf (AL21.DU).
Allscripts Healthcare Solutions Inc is an American company specializing in providing IT solutions for healthcare providers. The company was founded in 1986 as a small software firm in Chicago and has since become one of the leading providers of electronic health records and other health IT solutions. Allscripts offers a wide range of products and services to meet the needs of healthcare providers of all sizes and types. The various business areas of Allscripts include hospitals and health systems, physician practices, accountable care organizations (ACOs), and pharmacies. Allscripts' products and services are designed to increase the efficiency of healthcare providers, improve the quality of patient care, and meet the growing demand for connected healthcare. In the hospital and health systems area, Allscripts offers a comprehensive portfolio of solutions to meet the complex requirements of large and complex health systems. This includes electronic health records, laboratory and imaging management, portfolio management, revenue cycle management, and reporting. In the physician practices area, Allscripts provides a variety of solutions to increase the efficiency of individual practices and smaller group practices. Products in this area include electronic health records, appointment scheduling, billing, prescription management, and patient portals. For ACOs, Allscripts offers a variety of solutions to support the community of healthcare facilities and providers. This includes solutions for collaboration management, population health management, and the automation of clinical workflows. Allscripts' solutions are also of interest to pharmacies. Allscripts offers solutions for optimizing inventory management, billing, and patient care. The company relies on state-of-the-art IT solutions and implements industry-leading methods for data analysis. Allscripts employs over 8,600 employees and has customers in over 190 countries. The company demonstrates its commitment to innovation in the healthcare industry through the development of new products and services. For example, a program to enhance the functionality of implanted pacemakers was recently introduced, which can be operated directly from a smartphone via a secure cloud system. With the introduction of new products and solutions, Allscripts aims to further expand its business in the healthcare sector and strengthen its position as a leading provider of health IT solutions. In summary, Allscripts Healthcare Solutions Inc is a leading provider of health IT solutions that offers a wide range of products and services for healthcare providers of all sizes and types. Allscripts aims to make healthcare more sustainable, digital, and connected, and to increase the efficiency of the healthcare system through innovative solutions.
The revenue cannot currently be calculated for Veradigm.
The expected profit of Veradigm is 32.67 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Veradigm is currently 19.53. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Veradigm stock.
The P/S cannot be calculated for Veradigm currently.
The Eulerpool Quality Score for Veradigm is 0/10.
The ISIN of Veradigm is US01988P1084. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Veradigm is 607917. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Veradigm is MDRX. The ticker symbol is used to trade Veradigm shares on the stock exchange.
Veradigm stock
Veradigm Peer Group
Veradigm Ticker
Veradigm FIGI
All fundamentals and in-depth analysis of Veradigm
Our stock analysis for Veradigm stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Veradigm. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.